MSB 2.03% $1.45 mesoblast limited

negative comments., page-5

  1. 7,294 Posts.
    lightbulb Created with Sketch. 564
    I would like if they can say

    1- And what about all other drugs and phases..are they also supporting ?

    2- Considering they are "investigating" the efficency can we be safe the events happen at that stage are good enough to go ahead with the phase 3 ?

    3- Considering they want to publish and interim report can they explain what is the reason and what for ?


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.